Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Amoéba

Market Cap 52.28M 60.54M 48.18M 45.1M 84.52M 5.75B 85.83M 569M 222M 2.8B 227M 222M 9.7B P/E Ratio 2026 *
-10.1x
P/E Ratio 2027 * 75.9x
Enterprise Value 63.43M 73.44M 58.45M 54.72M 103M 6.98B 104M 690M 269M 3.4B 276M 270M 11.77B EV / Sales 2026 *
12.4x
EV / Sales 2027 * 4.12x
Free-Float
90.78%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 60 14/12/2023
Chief Tech/Sci/R&D Officer - 01/09/2018
Corporate Officer/Principal - 01/03/2022
Director TitleAgeSince
Director/Board Member - 01/06/2014
Chairman 70 14/12/2023
Director/Board Member 70 25/05/2023
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-11.21% - - 60.54M
+4.00%-5.02%-9.41%-14.48% 3.32B
+0.42%-0.35%+73.85%+27.53% 2.86B
+2.72%+0.50%-17.91%-30.94% 2B
+1.78%-1.50%+14.42%-0.45% 1.56B
+2.66%-1.06%-29.91% - 1.49B
+5.66%-1.25%-6.37%-42.48% 1.48B
+4.38%-4.77%+18.36%+11.04% 1.47B
+9.99%+7.76%-15.89%+22.04% 1.4B
-0.33%-12.29%-33.71%+63.09% 1.06B
Average +3.13%+2.05%-0.73%+4.42% 1.85B
Weighted average by Cap. +3.30%+2.28%+4.92%+1.26%

Financials

2026 *2027 *
Net sales 5.1M 5.9M 4.7M 4.4M 8.24M 561M 8.37M 55.49M 21.64M 273M 22.16M 21.69M 946M 15.55M 18M 14.33M 13.41M 25.14M 1.71B 25.53M 169M 65.97M 833M 67.57M 66.13M 2.88B
Net income -5.2M -6.02M -4.79M -4.49M -8.41M -572M -8.54M -56.58M -22.06M -279M -22.6M -22.11M -964M 550K 637K 507K 474K 889K 60.53M 903K 5.98M 2.33M 29.46M 2.39M 2.34M 102M
Net Debt 11.15M 12.91M 10.27M 9.62M 18.02M 1.23B 18.3M 121M 47.3M 597M 48.45M 47.42M 2.07B 11.85M 13.72M 10.92M 10.22M 19.16M 1.3B 19.45M 129M 50.27M 635M 51.49M 50.4M 2.2B
Logo Amoéba
Amoéba is a greentech company whose ambition is to become a major player in the treatment of microbiological risk based on the patented use of amoebae in the plant protection and cosmetics sectors. With know-how that is unique in the world and protected by numerous patents, Amoéba is currently the only company capable of exploiting the full potential of the Willaertia amoeba on an industrial scale and cultivating it in sufficient volumes to offer biological solutions that constitute a viable alternative to the chemical products widely used today. Amoéba is currently focusing on the global biocontrol market for plant protection and on the cosmetics market.
Employees
-
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!